Menu
Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

Novocastra p16 antibody demonstrated an agreement of 98% with the Roche p16 antibody

Overview

The study compared the percentage agreement rates of Novocastra’s p16 (6H12) IVD solution with Roche CINtec® Histology p16 assay on 170 oropharyngeal cancer cases.

Selvam Thavaraj, PhD FDSRCS FRCPath

Selvam Thavaraj, PhD FDSRCS FRCPath
  • Senior Lecturer in Oral & Maxillofacial Pathology, King’s College London
  • Honorary Consultant in Head & Neck Pathology at Guy’s & St Thomas’ NHS Foundation

Research interests

  • Biomarkers and the role of microbes in head and neck premalignancy and cancer
  • Diagnostic and prognostic aspects of human papillomavirus in head and neck cancer

The webinar will include

  • Method used to conduct the study including study parameters
  • Discussion and results, including agreement with HPV DNA ISH and PCR
  • A chance to submit questions for feedback on the topic